该研究遵循剂量递增和年龄递减的模式,首先给成...查看全文
一个劳苦大众2021-06-24 06:53
$Applied Genetic(AGTC)$ Applied Genetic Technologies shares are trading higher after the company announced that it plans to release 12-month data for adult patients and low-dose pediatric patients in its Phase 1/2 clinical Achromatopsia trials on Thursday, June 24, 2021.查看全文
chuminhua2021-04-14 16:28
4月13日,TeamedON International,Inc.,一家致力于推进罕见疾病(包括眼科适应症)基因治疗的生物技术公司和生物技术公司Applied Genetic Technologies Corporation(纳斯达克:AGTC)$Applied Genetic(AGTC)$ ,该公司正在进行以腺相关病毒(AAV)为基础的基因疗法治疗罕见疾病的人体临床试验,...查看全文
$Applied Genetic(AGTC)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-22-123460 Act: 34 Size: 70 KB 网页链接
$Applied Genetic(AGTC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-22-293934 Act: 34 Size: 162 KB 网页链接
$Applied Genetic(AGTC)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-22-293929 Act: 34 Size: 22 KB 网页链接
$Applied Genetic(AGTC)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-22-122645 Act: 34 Size: 54 KB 网页链接
$Applied Genetic(AGTC)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-22-292998 Act: 34 Size: 36 KB 网页链接
$Applied Genetic(AGTC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-22-291655 Act: 34 Size: 167 KB 网页链接
$Applied Genetic(AGTC)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-22-291120 Act: 34 Size: 36 KB 网页链接
$Applied Genetic(AGTC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-22-289919 Act: 34 Size: 3 MB 网页链接
$Applied Genetic(AGTC)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-22-288961 Act: 34 Size: 45 KB 网页链接
$Applied Genetic(AGTC)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-22-118754 Act: 34 Size: 27 KB 网页链接